Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LRRK2”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Early research (Phase 1)Study completedNCT03710707
What this trial is testing

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

Who this might be right for
Parkinson Disease
Denali Therapeutics Inc. 29
Early research (Phase 1)Ended earlyNCT01424475
What this trial is testing

LRRK2 Mutation and Parkinson's Disease

Who this might be right for
Parkinson Disease
GlaxoSmithKline 5
Not applicableEnded earlyNCT05349019
What this trial is testing

A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease

Who this might be right for
Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene
Escape Bio, Inc. 22
Not applicableUnknownNCT01730599
What this trial is testing

A Longitudinal Study in Parkinson's Disease (PD) Patients

Who this might be right for
Parkinson's Disease
Tel-Aviv Sourasky Medical Center 200
Not applicableUnknownNCT02319382
What this trial is testing

Measure of Microglial Activation in the Brain of Parkinson Disease Patients With PET

Who this might be right for
Parkinson's Disease With LRRK2 MutationHealthy ControlsParkinson's Disease Without LRRK2 Mutation
Assistance Publique - Hôpitaux de Paris 46
Not applicableUnknownNCT04214509
What this trial is testing

LIPAD - LRRK2 International Parkinson's Disease Study

Who this might be right for
Parkinson's Disease and Parkinsonism
University of Luebeck 4,000
Early research (Phase 1)Study completedNCT04056689
What this trial is testing

Study to Evaluate DNL151 in Subjects With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Biogen 36
Not applicableStudy completedNCT03545425
What this trial is testing

Fox BioNet Project: LRRK2-002

Who this might be right for
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research 114
Not applicableStudy completedNCT03866603
What this trial is testing

Rostock International Parkinson's Disease Study (ROPAD)

Who this might be right for
Parkinson´s Disease
CENTOGENE GmbH Rostock 20,112
Not applicableStudy completedNCT01085227
What this trial is testing

Clinical, Molecular and by Neuroimaging of LRRK2 Mutations

Who this might be right for
Parkinson's Disease
Institut National de la Santé Et de la Recherche Médicale, France 50
Not applicableNot Yet RecruitingNCT07681219
What this trial is testing

LRRK2 (Leucine-Rich Repeat Kinase 2) Parkinson's Disease Fingerprint

Who this might be right for
Parkinsons Disease (PD)LRRK2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Very early researchStudy completedNCT05837130
What this trial is testing

Non-drug Treatment Study in Parkinson's Disease Patients and Healthy Volunteers to Collect Biological Samples in Order to Assess ex Vivo the Activity of Candidate Therapies and Develop Novel Analytical Methods for Biomarkers

Who this might be right for
Parkinson Disease
Servier 45
Not applicableStudy completedNCT03775447
What this trial is testing

Fox BioNet Project: ECV-003

Who this might be right for
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research 38
Not applicableStudy completedNCT04668898
What this trial is testing

LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease

Who this might be right for
Parkinson DiseaseLRRK2GBA Gene Mutation
Icahn School of Medicine at Mount Sinai 203
Not applicableStudy completedNCT04349865
What this trial is testing

LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers

Who this might be right for
Parkinson Disease
Xuanwu Hospital, Beijing 211
Not applicableStudy completedNCT05287620
What this trial is testing

Objective, Passive Assessment of LRRK2 Carriers

Who this might be right for
Parkinson Disease
University of Rochester 10
Not applicableStudy completedNCT03782753
What this trial is testing

Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's Disease

Who this might be right for
Parkinson Disease, PARK8Parkinson DiseaseIdiopathic Parkinson Disease
King's College London 59
Not applicableUnknownNCT04436848
What this trial is testing

LRRK2 G2385R Leucocyte and Urine Biomarker Study

Who this might be right for
Parkinson Disease
University of Malaya 150
Large-scale testing (Phase 3)Ended earlyNCT05418673
What this trial is testing

Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale

Who this might be right for
Parkinson Disease
Biogen 7
Testing effectiveness (Phase 2)Looking for participantsNCT07020026
What this trial is testing

Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease

Who this might be right for
Parkinson's Disease
Michael J. Fox Foundation for Parkinson's Research 60
Next Page